Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination

Avian Pathology

Volumn 40, Issue 4, 2011, Pages 395-403

  Gimeno, Isabel M ^a   Cortes, Aneg L ^a   Guy, James S ^a   Turpin, Elizabeth ^b   Williams, Christopher ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; BLOOD; CHICK EMBRYO; CHICKEN; FEMALE; GENETICS; GERMFREE ANIMAL; HERPES VIRUS INFECTION; ILTOVIRUS; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENIC ORGANISM; TURKEY (BIRD); VACCINATION; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CHICK EMBRYO; CHICKENS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; INJECTIONS, SUBCUTANEOUS; ORGANISMS, GENETICALLY MODIFIED; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; TURKEYS; VACCINATION; VACCINES, SYNTHETIC; VIRAL LOAD; VIRAL VACCINES; VIRUS REPLICATION;

GALLID HERPESVIRUS 1; GALLUS GALLUS; MELEAGRID HERPESVIRUS 1; SPONDIAS PURPUREA;

EID: 79961146995     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079457.2011.588196     Document Type: Article

References (38)

1. Abdul-Careem, M.F., Hunter, D.B., Lambourne, M.D., Read, L.R., Parvizi, P. & Sharif, S. (2008). Expression of cytokine genes following pre-and post-hatch immunization of chickens with herpesvirus of turkeys. Vaccine, 26, 2369-2377.
2. Bacon, L.D. & Witter, R.L. (1993). Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes. Avian Diseases, 37, 53-59.
3. Bacon, L.D. & Witter, R.L. (1994a). B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens. Poultry Science, 73, 481-487.
4. Bacon, L.D. & Witter, R.L. (1994b). Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Avian Diseases, 38, 65-71.
5. Bagust, T.J. & Johnson, M.A. (1995). Avian infectious laryngotracheitis: virus-host interactions in relation to prospects for eradication. Avian Pathology, 24, 373-391.
6. Baigent, S.J., Smith, L.P., Currie, R.J.W. & Nair, V.K. (2007). Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model. Avian Pathology, 36, 467-474.
7. Brandly, C.A. & Bushnell, L.D. (1934). A report of some investigations of infectious laryngotracheitis. Poultry Science, 13, 212-217.
8. Calnek, B.W. & Smith, M.W. (1972). Vaccination against Marek's disease with cell-free turkey herpesvirus: interference by maternal antibody. Avian Diseases, 16, 954-957.
9. Clarke, J.K., Robertson, G.M. & Purcell, D.A. (1980). Spray vaccination of chickens using infectious laryngotracheitis virus. Australian Veterinary Journal, 56, 424-428.
10. Cortes, A.L., Montiel, E.R. & Gimeno, I.M. (2009). Validation of Marek's disease diagnosis and monitoring of Marek's disease vaccines from samples collected in FTA cards. Avian Diseases, 53, 510-516.
11. Cortes, A.L., Montiel, E.R., Lemiere, S. & Gimeno, I.M. (2011). Comparison of blood and feather pulp samples for the diagnosis of Marek's disease and for monitoring Marek's Disease vaccination by real time PCR Avian Diseases, accepted for publication.
12. Cui, X., Lee, L.F., Reed, W.M., Kung, H.J. & Reddy, S.M. (2004). Marek's disease virus-encoded vIL-8 gene is involved in early cytolytic infection but dispensable for establishment of latency. Journal of Virology, 78, 4753-4760.
13. Davison, S., Gingerich, E.N., Casavant, S. & Eckroade, R.J. (2006). Evaluation of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/avian encephalomyelitis vaccine against ILT viral challenge. Avian Diseases, 50, 50-54.
14. Devlin, J.M., Browning, G.F., Gilkerson, J.R., Fenton, S.P. & Hartley, C.A. (2008). Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol. Avian Pathology, 37, 83-88.
15. Dufour-Zavala, L. (2008). Epizootiology of infectious laryngotracheitis and presentation of an industry control program. Avian Diseases, 52, 1-7.
16. Gelenczei, E.F. & Marty, E.W. (1965). Strain stability and immunologic characteristics of a tissue-culture-modified infectious laryngotracheitis virus. Avian Diseases, 14, 44-56.
17. Gimeno, I.M., Cortes, A.L. & Silva, R.F. (2008). Load of challenge Marek's disease virus DNA in blood as a criterion for early diagnosis of Marek's disease tumors. Avian Diseases, 52, 203-208.
18. Gimeno, I.M., Cortes, A.L., Montiel, E.R., Lemiere, S. & Pandiri, A.K. (2011). Effect of dilutingMarek's disease vaccines on the outcomes of Marek's disease virus infection when challenged with highly virulent Marek's disease viruses. Avian Diseases, in press.
19. Gimeno, I.M., Witter, R.L., Hunt, H.D., Reddy, S.M., Lee, L.F. & Silva, R.F. (2005). The pp38 gene of Marek's disease virus (MDV) is necessary for cytolytic infection of B cells and maintenance of the transformed state but not for cytolytic infection of the feather follicle epithelium and horizontal spread of MDV. Journal of Virology, 79, 4545-4549.
20. Guy, J.S. & Bagust, T.J. (2003). Laryngotracheitis. In Y.M. Saif, H.J. Barnes, A. Fadly, J.R. Glisson, L.R. McDougald & D.E. Swayne (Eds.). Diseases of Poultry 11th edn (pp. 121-134). Ames, Iowa: Iowa State University Press.
21. Guy, J.S., Barnes, H.J. & Smith, L.G. (1991). Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Diseases, 35, 348-355.
22. Guy, J.S., Barnes, H.J., Munger, L.L. & Rose, L. (1989). Restriction endonuclease analysis of infectious laryngotracheitis viruses: comparison of modified-live vaccine viruses and North Carolina field isolates. Avian Diseases, 33, 316-323.
23. Guy, J.S., Gimeno, I.M. & West, M. (2011). Experimental evaluation of in ovo-administered recombinant virus-vectored laryngotracheitis virus vaccines for prevention of disease in broiler chickens. Avian Pathology, submitted.
24. Johnson, D.I., Vagnozzi, A., Dorea, F., Riblet, S.M., Mundt, A., Zavala, G. & Garcia, M. (2010). Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Avian Diseases, 54, 1251-1259.
25. King, D.D., Page, D., Schat, K.A. & Calnek, B.W. (1981). Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines. Avian Diseases, 25, 74-81.
26. Kuhnlein, U., Spencer, J.L., Chan, M., Praslickova, D., Linher, K., Kulenkamp, A. & Ansah, G. (2006). Relationship between Marek's disease and the time course of viral genome proliferation in feather tips. Avian Diseases, 50, 173-178.
27. Landman, W.J. & Verschuren, S.B. (2003). Titration of Marek's disease cell-associated vaccine virus (CVI 988) of reconstituted vaccine and vaccine ampoules from Dutch hatcheries. Avian Dieases, 47, 1458-1465.
28. Lee, L.F. & Witter, R.L. (1991). Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine. Avian Diseases, 35, 452-459.
29. Lee, L.E., Witter, R.L., Reddy, S.M., Wu, P., Yanagida, N. & Yoshida, S. (2003). Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus. Avian Diseases, 47, 549-558.
30. Lupiani, B., Lee, L.F., Cui, X., Gimeno, I.M., Anderson, A., Morgan, R.W., et al. (2004). Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proceedings of the National Acadamey of Science of the United States of America, 101, 11815-11820.
31. Morgan, R.W., Kent, J. & Anderson, A.S. (1998). Marek's disease virus gC and meq mutants with dramatic reductions in tumour incidences and horizontal transmission. Avian Pathology, 27, S88-S89.
32. Nazerian, K., Witter, R.L., Lee, L.F. & Yanagida, N. (1996). Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Avian Diseases, 40, 368-376.
33. Purcell, D.A. & Surman, P.G. (1974). Letter: Aerosol administration of the SA-2 vaccine strain of infectious laryngotracheitis virus. Australian Veterinary Journal, 50, 419-420.
34. Robertson, G.M. & Egerton, J.R. (1981). Replication of infectious laryngotracheitis virus in chickens following vaccination. Australian Veterinary Journal, 57, 119-123.
35. Samberg, Y. & Aronovici, I. (1969). The development of a vaccine against avian infectious laryngotracheitis. 1. Modification of a laryngotracheitis virus. Refuah Veterinarith, 26, 54-59.
36. Schumacher, D., Tischer, B.K., Fuchs, W. & Osterrieder, N. (2000). Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negativeMDV-1 mutant. Journal of Virology, 74, 11088-11098.
37. Swaggerty, C.L., Pevzner, I.Y., Kaiser, P. & Kogut, M.H. (2008). Profiling pro-inflammatory cytokine and chemokine mRNA expression levels as a novel method for selection of increased innate immune responsiveness. Veterinary Immunology and Immunopathology, 126, 35-42.
38. Tong, G.Z., Zhang, S.J., Meng, S.S., Wang, L., Qiu, H.J., Wang, Y.F., et al. (2001). Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathology, 30, 143-148.